{
 "context": "The following article called 'MTBC Declares Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock' was published on 2018-03-12. The body of the article is as follows:\n    \nSOMERSET, N.J, March 12, 2018 (GLOBE NEWSWIRE) --\nMTBC (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced that its Board of Directors has declared monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (\u201cSeries A Preferred Stock\u201d) for March, April and May 2018. This represents 30 consecutive months of dividends declared since the Series A Preferred Stock was initially sold in November 2015.\nHolders of shares of the Series A Preferred Stock are entitled to receive cumulative cash dividends at the rate of 11% per annum of the $25.00 per share liquidation preference (equivalent to $2.75 per annum per share). Dividends on the Series A Preferred Stock are payable monthly on the 15 th day of each month; provided that if any dividend payment date is not a business day, then the dividend may be paid on the next succeeding business day. Dividends are payable to holders of record on the applicable record date, which shall be the last day of the calendar month, whether or not a business day.\nMTBC\u2019s Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol \u201cMTBCP.\u201d\nThe following table shows the monthly dividends and associated record and payment dates:\nMarch 2018 April 2018 May 2018 Dividend per share $0.22917 $0.22917 $0.22917 Ex-dividend date March 29, 2018 April 27, 2018 May 30, 2018 Record date March 31, 2018 April 30, 2018 May 31, 2018 Payment date April 16, 2018 May 15, 2018 June 15, 2018 About MTBC\nMedical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol \u201cMTBC,\u201d and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol \u201cMTBCP.\"\nFor additional information, please visit our website at www.MTBC.com .\nFollow MTBC on TWITTER , LINKEDIN and FACEBOOK .\nSOURCE MTBC\nDisclaimer\nThis press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.\nCompany Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. bkorn@mtbc.com (732) 873-5133\nSource: MTBC\n\n    The day before the article was published, the stock price of Medical Transcription Billing, Corp. was 3.569999933242798 and the day after the article was published, the stock price of Medical Transcription Billing, Corp. was ",
 "expected": "3.5999999046325684",
 "date": "2018-03-12",
 "ticker": "MTBC",
 "company": "Medical Transcription Billing, Corp.",
 "url": "http://www.cnbc.com/2018/03/12/globe-newswire-mtbc-declares-dividends-on-non-convertible-series-a-cumulative-redeemable-perpetual-preferred-stock.html"
}